Actively Recruiting
Phase II Study Comparing Haploidentical T-cell Depleted Stem Cell Transplantation to Matched Sibling Donor Transplantation in Patients Aged 2 to 35 With Sickle Cell Disease Without a Sibling Donor
Led by University of Regensburg · Updated on 2024-05-13
212
Participants Needed
9
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating whether a haploidentical alphabeta and CD19 T-cell depleted hematopoietic stem cell transplantation HSCT can be a safe and effective alternative to matched sibling donor MSD transplantation for patients with sickle cell disease SCD who lack a suitable sibling donor. This Phase II trial focuses on improving disease-free survival while minimizing adverse events, graft rejection, and graft-versus-host disease GvHD. The study aims to offer a curative option for a wider group of patients beyond those with MSDs, addressing current challenges in non-malignant disease treatment. The trial compares two approaches the experimental arm involves haploidentical 510 HSCT from a relative with alphabeta T-cell depletion, and the control arm uses 1010 matched sibling donor transplantation. It evaluates the safety and efficacy of the less aggressive conditioning regimen combined with TCR alphabeta and CD19 depleted grafts to reduce severe GvHD and graft failure. Both groups undergo transplantation procedures aligned with their donor type, with the experimental approach aiming to speed immune system recovery and reduce transplantation-related mortality. Participants are children and young adults aged 2 to 35 years with severe or moderate SCD complications. The study tracks event-free survival up to 180 days post-transplant and follows participants for up to two years to assess overall survival, disease-free survival, graft failure, and quality of life using standardized questionnaires. Researchers monitor immune recovery, fertility, and adverse events throughout, ensuring comprehensive safety and efficacy evaluations during and after transplantation.
CONDITIONS
Brief Title
A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD
Research Team
S
Selim Corbacioglu, MD
K
Katharina Kleinschmidt, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here